Question ID:
Legal Act:
Regulation (EU) No 575/2013 (CRR)
Large exposures
COM Delegated or Implementing Acts/RTS/ITS/GLs/Recommendations:
Not applicable
Disclose name of institution / entity:
Type of submitter:
Credit institution
Subject Matter:
Exposure Value under the Equity method of accounting

What exposure value should be used for Large Exposure purposes in situations where there is a difference between the accounting value used for IFRS accounting purposes and the value used for FinRep regulatory purposes?

Background on the question:

The Large Exposure template instructions expand on Article 390 CRR and state that ‘The valuation of assets and off-balance-sheet items shall be effected in accordance with the accounting framework to which the institution is subject, according to Article 24 of CRR’.


On the other hand, Article 18(5) CRR, permits the equity method of accounting to be used for the consolidation of subsidiaries which have not otherwise been consolidated under Articles 18(1)-(4).


In a situation where the application of the equity method of accounting is required for regulatory purposes and where this differs from the method applied from an IFRS accounting perspective, it is unclear whether  the equity method of accounting could be used for LE purposes, consistently with the determination under of Article 18(5).


Article 390 CRR does not address the actual value to be applied in all cases, e.g. the application of Article 18(5), equity method of accounting, in the valuation for Large exposures. This potential conflict appears to have been considered for FINREP (see Q&A 340, which might be helpful in addressing the issue, in the sense of explaining and confirming the change of value used under the accounting framework to the value used for FinRep.


The reporting instructions (Annex IX for Large Exposures) - specifically for the original exposure col 010 which say to use “the accounting framework to which the institution is subject” -  appears to require accounting value to be the value recorded in the bank's own financial statements under IFRs

Date of submission:
Published as Rejected Q&A
Rationale for rejection:

Please note that as part of adjustments to the Single Rulebook Q&A process, agreed by the EBA and the European Commission, it has been decided to reject outstanding questions submitted before 1 January 2020, when the Q&A process was updated as part of the last ESAs Review. In particular, the question that you have submitted has now regrettably been rejected and will not be addressed.

If you believe your question would still benefit from clarification, you are invited to resubmit your question, adapting it to reflect any legislative, regulatory or other relevant developments that may have occurred since the initial date of submission. The EBA will aim to address resubmitted questions as a matter of priority. When considering to resubmit, you are kindly requested to observe the updated admissibility criteria agreed in the context of the adjustment of the Q&A process, available in the Additional background and guidance for asking questions. We hope for your understanding.

For further information please refer to the press release and the updated Q&A page.

Rejected question